New marker of drug response may speed pace of lung cancer prevention trials
January 8, 2013 · Comments Off
Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years for results. A possible waypoint on the way to benefit may dramatically speed testing.
How chronic obstructive pulmonary disease increases risk of lung cancer
July 24, 2012 · Comments Off
In addition to the well-known risk factor of smoking, chronic obstructive pulmonary disease (COPD) increases lung cancer risk.
Milk thistle shows promise for prevention of colorectal cancer in new CU Cancer Center study
October 1, 2010 · Comments Off
Silibinin (a milk thistle extract active agent)decreased the growth of colon tumors in mice when...
NTRK1: a new oncogene and target in lung cancer
October 1, 2010
“Dramatic” Early Phase 1 Results for AG-120 in IDH1 Mutated AML
November 24, 2014 · No comments
University of Colorado Hospital Now Offering Lung Cancer Screening
November 13, 2014 · No comments
CU Cancer Center brings specialty care to Colorado
November 12, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer clinical trials cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith